138 related articles for article (PubMed ID: 29572862)
1. Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.
Tedder RS; Samuel D; Dicks S; Scott JT; Ijaz S; Smith CC; Adaken C; Cole C; Baker S; Edwards T; Kamara P; Kargbo O; Niazi S; Nwakanma D; d'Alessandro U; Burch G; Doughty H; Brown CS; Andrews N; Glynn JR; van Griensven J; ; Pollakis G; Paxton WA; Semple MG
Transfusion; 2018 May; 58(5):1289-1298. PubMed ID: 29572862
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States.
Dean CL; Hooper JW; Dye JM; Zak SE; Koepsell SA; Corash L; Benjamin RJ; Kwilas S; Bonds S; Winkler AM; Kraft CS
Transfusion; 2020 May; 60(5):1024-1031. PubMed ID: 32129478
[TBL] [Abstract][Full Text] [Related]
3. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
[TBL] [Abstract][Full Text] [Related]
4. Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.
Brown JF; Dye JM; Tozay S; Jeh-Mulbah G; Wohl DA; Fischer WA; Cunningham CK; Rowe K; Zacharias P; van Hasselt J; Norwood DA; Thielman NM; Zak SE; Hoover DL
J Infect Dis; 2018 Jul; 218(4):555-562. PubMed ID: 29659889
[TBL] [Abstract][Full Text] [Related]
5. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study.
Halfmann PJ; Eisfeld AJ; Watanabe T; Maemura T; Yamashita M; Fukuyama S; Armbrust T; Rozich I; N'jai A; Neumann G; Kawaoka Y; Sahr F
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007654. PubMed ID: 31369554
[TBL] [Abstract][Full Text] [Related]
6. EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone.
Colavita F; Biava M; Mertens P; Gilleman Q; Borlon C; Delli Guanti M; Petrocelli A; Cataldi G; Kamara AT; Kamara SA; Konneh K; Vincenti D; Castilletti C; Abdurahman S; Mirazimi A; Capobianchi MR; Ippolito G; Miccio R; Di Caro A
Clin Microbiol Infect; 2018 Jun; 24(6):653-657. PubMed ID: 29107122
[TBL] [Abstract][Full Text] [Related]
7. Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study.
Semper AE; Broadhurst MJ; Richards J; Foster GM; Simpson AJ; Logue CH; Kelly JD; Miller A; Brooks TJ; Murray M; Pollock NR
PLoS Med; 2016 Mar; 13(3):e1001980. PubMed ID: 27023868
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus antibody decay-stimulation in a high proportion of survivors.
Adaken C; Scott JT; Sharma R; Gopal R; Dicks S; Niazi S; Ijaz S; Edwards T; Smith CC; Cole CP; Kamara P; Kargbo O; Doughty HA; van Griensven J; Horby PW; Gevao SM; Sahr F; ; Dimelow RJ; Tedder RS; Semple MG; Paxton WA; Pollakis G
Nature; 2021 Feb; 590(7846):468-472. PubMed ID: 33505020
[TBL] [Abstract][Full Text] [Related]
9. Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses.
Gunn BM; Roy V; Karim MM; Hartnett JN; Suscovich TJ; Goba A; Momoh M; Sandi JD; Kanneh L; Andersen KG; Shaffer JG; Schieffelin JS; Garry RF; Grant DS; Alter G
J Infect Dis; 2020 Jan; 221(1):156-161. PubMed ID: 31301137
[TBL] [Abstract][Full Text] [Related]
10. Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.
Williamson LE; Flyak AI; Kose N; Bombardi R; Branchizio A; Reddy S; Davidson E; Doranz BJ; Fusco ML; Saphire EO; Halfmann PJ; Kawaoka Y; Piper AE; Glass PJ; Crowe JE
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728263
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.
Sahr F; Ansumana R; Massaquoi TA; Idriss BR; Sesay FR; Lamin JM; Baker S; Nicol S; Conton B; Johnson W; Abiri OT; Kargbo O; Kamara P; Goba A; Russell JB; Gevao SM
J Infect; 2017 Mar; 74(3):302-309. PubMed ID: 27867062
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus.
Glynn JR; Bower H; Johnson S; Houlihan CF; Montesano C; Scott JT; Semple MG; Bangura MS; Kamara AJ; Kamara O; Mansaray SH; Sesay D; Turay C; Dicks S; Wadoum REG; Colizzi V; Checchi F; Samuel D; Tedder RS
Lancet Infect Dis; 2017 Jun; 17(6):645-653. PubMed ID: 28256310
[TBL] [Abstract][Full Text] [Related]
13. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
Houlihan CF; McGowan CR; Dicks S; Baguelin M; Moore DAJ; Mabey D; Roberts CH; Kumar A; Samuel D; Tedder R; Glynn JR
PLoS Med; 2017 May; 14(5):e1002300. PubMed ID: 28510604
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West Africa.
Colavita F; Biava M; Castilletti C; Lanini S; Miccio R; Portella G; Vairo F; Ippolito G; Capobianchi MR; Di Caro A; Lalle E
Viruses; 2019 Apr; 11(4):. PubMed ID: 31018522
[TBL] [Abstract][Full Text] [Related]
15. Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study.
Abbate JL; Murall CL; Richner H; Althaus CL
PLoS Negl Trop Dis; 2016 May; 10(5):e0004676. PubMed ID: 27135922
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone.
Ji YJ; Duan XZ; Gao XD; Li L; Li C; Ji D; Li WG; Wang LF; Meng YH; Yang X; Ling BF; Song XA; Gu ML; Jiang T; Koroma SM; Bangalie J; Duan HJ
Infect Dis Poverty; 2016 Nov; 5(1):101. PubMed ID: 27806732
[TBL] [Abstract][Full Text] [Related]
17. Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.
Luczkowiak J; Lasala F; Mora-Rillo M; Arribas JR; Delgado R
J Infect Dis; 2018 Nov; 218(suppl_5):S574-S581. PubMed ID: 29939289
[TBL] [Abstract][Full Text] [Related]
18. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone.
Shantha JG; Mattia JG; Goba A; Barnes KG; Ebrahim FK; Kraft CS; Hayek BR; Hartnett JN; Shaffer JG; Schieffelin JS; Sandi JD; Momoh M; Jalloh S; Grant DS; Dierberg K; Chang J; Mishra S; Chan AK; Fowler R; O'Dempsey T; Kaluma E; Hendricks T; Reiners R; Reiners M; Gess LA; ONeill K; Kamara S; Wurie A; Mansaray M; Acharya NR; Liu WJ; Bavari S; Palacios G; Teshome M; Crozier I; Farmer PE; Uyeki TM; Bausch DG; Garry RF; Vandy MJ; Yeh S
EBioMedicine; 2018 Apr; 30():217-224. PubMed ID: 29622497
[TBL] [Abstract][Full Text] [Related]
19. Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay.
Jansen van Vuren P; Grobbelaar A; Storm N; Conteh O; Konneh K; Kamara A; Sanne I; Paweska JT
J Clin Microbiol; 2016 Feb; 54(2):359-67. PubMed ID: 26637383
[TBL] [Abstract][Full Text] [Related]
20. The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.
van Griensven J; De Weiggheleire A; Delamou A; Smith PG; Edwards T; Vandekerckhove P; Bah EI; Colebunders R; Herve I; Lazaygues C; Haba N; Lynen L
Clin Infect Dis; 2016 Jan; 62(1):69-74. PubMed ID: 26261205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
